weight loss drug prescriptions semaglutide tirzepatide q3 2024 data vs Tirzepatide: Real Results Compared [2026] Tirzepatide shows 47% greater weight

The key consideration is ensuring the injection reaches the subcutaneous layer rather than into a vein or muscle

Both medications were initially developed to treat type 2 diabetes, but clinical results showing dramatic weight reductions sparked their evolution into tools for obesity management

However, many people develop a preference based on their side effect experience

Rejeesh Menon, MD Medical Director, SuperHuman Program Last reviewed 5 April 2026 Frequently Asked Questions FAQ: Mounjaro in India Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication that activates both GIP and GLP-1 receptors

In the SURMOUNT-1 trial studying tirzepatide for weight loss, nausea rates varied by dose

(3) Zepbound: approved December 2024 for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity making tirzepatide the first medication approved specifically for OSA